Skip to main content
AmigoFish

#374 The Eras of Genetic Testing: From the Human Genome Project to Precision Medicine

From DNA Today: A Genetics Podcast · · 45 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

What if we looked at genetic testing not just as a tool, but as a story unfolding through eras of innovation, access, and personal meaning?

To explore the genetic testing landscape over the last couple decades we are joined by a fellow podcaster Rome Madison, who is also a precision medicine expert and longtime industry leader with extensive experience working in diagnostics and precision medicine.

Rome has trained sales teams, helped launch groundbreaking cancer diagnostics, and now hosts Genetics for Healthcare: A Podcast for Patients (https://geneticsforhealthcare.com/). He’s here to share not only how genetic testing has evolved across different eras, but also his personal connection to the field and why he’s committed to ensuring patients benefit from the genomic revolution.

On This Episode, We Discuss:

Setting the Stage: Rome’s Personal Journey

- How Rome entered the genetics and diagnostics space shortly after the Human Genome Project

- What motivates his continued work at the intersection of innovation, patients, and access

- Why confidence, curiosity, and communication matter in fast-changing scientific fields

The Early Era: Post–Human Genome Project

- What diagnostics felt like in the early 2000s

- Early pharmacogenomics and predicting chemotherapy response

- Barriers to adoption, including cost, infrastructure, and skepticism

The Growth Era: Expansion of Genetic Testing

- How cancer diagnostics and precision medicine began shaping standard care

- Shifts in how clinicians and patients talked about risk and prevention

- Lessons learned about equity, access, and unmet expectations

The Current Era: Precision Medicine Goes Mainstream

- What distinguishes today’s genetic testing landscape from earlier eras

- Ongoing challenges around affordability, access, and education

- The role of podcasts and science communication in empowering patients

Looking Ahead: The Next Era of Genetic Testing

- What might define the next wave: RNA, epigenomics, microbiome, multi-omics

- Where AI and advanced data analytics fit into future care models

- Why collaboration across pharma, diagnostics, advocacy groups, and patients is essential

- Whether population-wide genetic testing could become routine in the years ahead

About the Guest Rome Madison (https://www.linkedin.com/in/genomicsellingsolutions/) helps people and organizations in the life science industry increase confidence, embrace uncertainty and navigate chaos to rise and win in the market. With over 20 years of experience leading sales teams and go-to market strategy for successful start-ups and new products, Rome has Unreasonable Confidence that cancer and other chronic genetic diseases can be prevented, detected early, treated effectively and cured.

Rome has given more than 500 live speeches and is a charismatic virtual presenter that keeps your audience glued to the screen and engaged with his content. He has appeared on more than 50 TV and radio shows across the US as a precision medicine expert, and has been a featured speaker at the Consumer Electronics Show on The Future of Healthcare.

Rome’s podcast, Genetics for Healthcare: A Podcast for Patients (https://geneticsforhealthcare.com/), unites major healthcare stakeholders to close the gap of innovation and patient access to precision medicine. He is co-creator and host of the award-winning Precision Medicine Podcast, Google’s #1 rated podcast on the topic of next-generation cancer care, with listeners in over 108 countries.

Relevant Resources:

- Genetics for Healthcare Podcast (https://geneticsforhealthcare.com/) Hosted by Rome Madison

- American Lung Association; EGFR and Lung Cancer (https://www.lung.org/lung-health-diseases/lung-disease-lookup/lung-cancer/symptoms-diagnosis/biomarker-testing/egfr)

- Breast Cancer Research Foundation; HER2-Positive Breast Cancer: Testing, Treatment, Research (https://www.bcrf.org/about-breast-cancer/her2-positive-breast-cancer-treatment-research/)

- Fierce…

Back to DNA Today: A Genetics Podcast · Report a problem